The results showed that cystatin C levels were significantly higher in tumor tissues than in normal tissues, but the immunohistochemical expression of cystatin C in non-neuroendocrine prostate cancer cells gradually decreased with increasing Gleason grade. The gene discussed is CST3; the disease is neoplasm.